Epidermis
neoplasma
Epidermis
neoplasma
Epidermis
neoplasma
BENIGN SQUAMOUS
KERATOSIS
neoplasma
SEBORRHEIC KERATOSIS
Seborrheic keratosis
Seborrheic keratosis
Seborrheic keratosis
neoplasma
10
Seborrheic keratosis
before
neoplasma
after
11
Seborrheic
keratosis
neoplasma
12
Seborrheic keratosis
neoplasma
13
ACTINIC KERATOSIS
Actinic keratosis
15
Actinic keratosis
neoplasma
Actinic keratosis
Risk factors:
Treatment:
fair skin,
ionizing radiation,
hydrocarbon or arsenic exposure,
renal transplant
curettage,
cryotherapy,
topical chemotherapeutic agents
17
Actinic keratosis
neoplasma
18
Actinic keratosis
neoplasma
19
Actinic keratosis
(HE) x 100
B2
B1
B3
neoplasma
Actinic keratosis
(a precancerous condition):
As a result of permanent
DNA damage,
the epidermal epithelium
exhibits nuclear
polymorphism ( B1) and
nuclear polychromasia
accompanied by excessive
formation of keratinized
corneal scales
(parakeratosis; B2).
However, these changes
do not penetrate the
basement membrane ( B3).
20
FIBROEPITHELIAL POLYP
Fibroepithelial polyp
Patterns:
22
Fibroepithelial polyp
Fibroepithelial polyp
24
25
neoplasma
26
neoplasma
27
neoplasma
28
Fibroepithelial polyp
neoplasma
29
PAPILLOMA
neoplasma
31
PAPILLOMA
neoplasma
32
PAPILLOMA
neoplasma
33
INTRADERMAL
PIGMENTED NEVI
Nevus Pigmentosus
neoplasma
35
Nevus Pigmentosus
Junctional type
Junctional nevus
(HE) x 25
neoplasma
37
Nevus Pigmentosus
compound type
38
Nevus Pigmentosus
dysplastic nevus
More pigmented and raised central zone (A: compound nevus component) and an
assymetric shoulder (B:junctional nevus component cytologic atypia: irregularly
shaped, dark staining nuclei). The dermis underlying atypical cells
linear or lamellar fibrosis desmoplasia.
neoplasma
39
PIGMENTED NEVI
neoplasma
40
MALIGNANT MELANOMA
Melanoma
42
44
Melanoma
S100:
HMB45:
Tyrosinase:
MelanA/Mart1:
45
Malignant Melanoma
47
Malignant Melanoma
neoplasma
48
Malignant Melanoma
radial growth phase of melanoma
Irregular nested and single cell growth of melanoma cells within the
epidermis and an underlying inflammatory response within the dermis
neoplasma
49
Malignant Melanoma
vertical phase growth
50
Malignant Melanoma
51
Nodular malignant
melanoma
(HE) x 10
neoplasma
52
Superficial spreading
melanoma
neoplasma
53
Superficial spreading
melanoma
(HE) X 100
neoplasma
54
MALIGNANT MELANOMA
neoplasma
55
LENTIGO
neoplasma
57
Lentiginous melanocytic
nevus
neoplasma
58
Lentigo maligna
59
Lentigo maligna
60
Lentigo maligna
neoplasma
61
neoplasma
62
BOWENS DISEASE
Bowens disease
64
65
66
Bowens disease
neoplasma
67
Bowens disease
neoplasma
68
SQUAMOUS CELL
CARCINOMA
SQUAMOUS CELL
CARCINOMA
70
Risk factors:
71
SQUAMOUS CELL
CARCINOMA
low stage,
no/superficial dermal invasion, small vertical tumor
thickness (< 4 mm),
well differentiated,
short duration,
location other than scalp, ears, lips, nose, eyelids or soft
tissue (which readily invade subcutaneous tissue)
72
73
SQUAMOUS CELL
CARCINOMA
Positive stains:
Negative stains:
74
Squamous Cell Ca
neoplasma
75
Squamous Cell Ca
neoplasma
76
neoplasma
77
neoplasma
78
neoplasma
79
neoplasma
80
Histopathologic criteria to
differentiate early
keratoacanthoma from a well to
moderately differentiated
squamous cell carcinoma (Ackerman et
al and Cribier et al)
TABLE ..
Keratoacanthoma
Squamous cell
carcinoma
Predominantly endophytic
with no horn-filled crater
Overhanging 'lips' of
epithelium
No epithelial 'lips'
Rarely ulcerated
Commonly ulcerated
Less common
Rare
Pseudoglandular formations
often
Lack of anaplasia
Common
Indistinct
82
Immunohistochemical expression of
telomerase activity, COX-2, and p53
in keratoacanthoma (KA) and
squamous cell carcinoma (SCC).
TABLE ..
KA a
SCC a 'P' value
(n=24 (n=17)
)
Telomerase
COX-2
p53
Negativeb
Weakc
Strongd
Negative
Weak
Strong
Negative
Weak
Strong
01(4.2)
20(83.3)
03(12.5)
16(66.7)
07(29.2)
01(4.2)
10(41.7)
13(54.2)
01 (4.2)
0 (0)
06(35.3)
11(64.7)
04(23.5)
04(23.5)
09(52.9)
02(11.8)
04(23.5)
11(64.7)
0.001
0.001
0.000
84
86
Risk factors:
87
neoplasma
88
neoplasma
89
QUIZ
Miniquiz
91
Figure 1 : Erythematous
pigmented
nodules of
forearms
neoplasma
92
93
Question :
What is the diagnosis of this
case ?
Answer:
Mastocytosis
Mastocytosis
96
Mastocytosis
97
neoplasma
98
Mastocytosis
neoplasma
99
neurofibromatosi
s
Type I neurofibromatosis
(skin)
neoplasma
101
S-100: neurofibroma
(IH) x 75
neoplasma
102